Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025
Bionano Genomics (Nasdaq: BNGO) has scheduled its second quarter 2025 financial results conference call and webcast for August 14, 2025, at 4:30 p.m. Eastern Time. The company will present its Q2 2025 financial performance and provide updates on recent corporate developments.
Investors and interested parties can access the live webcast through the company's investor relations website. A replay of the presentation will be available for at least 30 days after the event on Bionano's IR website at ir.bionano.com.
Bionano Genomics (Nasdaq: BNGO) ha programmato la conference call e la diretta web per i risultati finanziari del secondo trimestre 2025 il 14 agosto 2025 alle 16:30 ora della costa orientale. La società presenterà i risultati finanziari del Q2 2025 e fornirà aggiornamenti sugli sviluppi aziendali più recenti.
Investitori e interessati potranno seguire la diretta streaming tramite il sito web delle relazioni con gli investitori della società. Una registrazione della presentazione sarà disponibile per almeno 30 giorni dopo l’evento sul sito IR di Bionano all’indirizzo ir.bionano.com.
Bionano Genomics (Nasdaq: BNGO) ha programado su llamada de conferencia y webcast para los resultados financieros del segundo trimestre de 2025 el 14 de agosto de 2025 a las 4:30 p.m. hora del este. La compañía presentará su desempeño financiero del Q2 2025 y proporcionará actualizaciones sobre los desarrollos corporativos recientes.
Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas de la compañía. Una repetición de la presentación estará disponible durante al menos 30 días después del evento en el sitio IR de Bionano en ir.bionano.com.
Bionano Genomics (나스닥: BNGO)는 2025년 2분기 재무실적 컨퍼런스 콜 및 웹캐스트를 2025년 8월 14일 오후 4시 30분 동부 시간에 예정했습니다. 회사는 2025년 2분기 재무 성과를 발표하고 최근 기업 동향에 대해 업데이트할 예정입니다.
투자자 및 관심 있는 분들은 회사의 투자자 관계 웹사이트를 통해 실시간 웹캐스트에 접속할 수 있습니다. 발표 녹화는 행사 후 최소 30일간 Bionano 투자자 관계 웹사이트 ir.bionano.com에서 제공됩니다.
Bionano Genomics (Nasdaq : BNGO) a programmé sa conférence téléphonique et sa webdiffusion des résultats financiers du deuxième trimestre 2025 pour le 14 août 2025 à 16h30, heure de l'Est. La société présentera ses performances financières du T2 2025 et fournira des mises à jour sur les récents développements corporatifs.
Les investisseurs et les parties intéressées peuvent accéder à la webdiffusion en direct via le site des relations investisseurs de la société. Un replay de la présentation sera disponible pendant au moins 30 jours après l'événement sur le site IR de Bionano à ir.bionano.com.
Bionano Genomics (Nasdaq: BNGO) hat seine Telefonkonferenz und das Webcast zu den Finanzergebnissen des zweiten Quartals 2025 für den 14. August 2025 um 16:30 Uhr Eastern Time angesetzt. Das Unternehmen wird seine Finanzergebnisse für Q2 2025 vorstellen und Updates zu aktuellen Unternehmensentwicklungen geben.
Investoren und Interessierte können den Live-Webcast über die Investor-Relations-Website des Unternehmens verfolgen. Eine Aufzeichnung der Präsentation wird für mindestens 30 Tage nach der Veranstaltung auf der IR-Website von Bionano unter ir.bionano.com verfügbar sein.
- None.
- None.
SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, August 14, 2025, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2025 and to highlight recent corporate progress.
Conference Call & Webcast Details
| Date: | Thursday, August 14th, 2025 |
| Time: | 4:30 p.m. ET |
| Participant Link: | Registration – Click here |
| Webcast Link: | https://edge.media-server.com/mmc/p/tnombut6/ |
Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Kelly Gura
Gilmartin Group
+1 (212) 229-6163
IR@bionano.com
FAQ
When is Bionano Genomics (BNGO) reporting Q2 2025 earnings?
How can I access Bionano Genomics' Q2 2025 earnings call?
How long will Bionano's Q2 2025 earnings call replay be available?
Who can I contact for investor relations questions about Bionano Genomics (BNGO)?
